Additionally, inhibition of NF-κB activation resulted in increased sensitivity to vincristine in B-ALL cells cocultured with BM-MSCs, suggesting that NF-κB activation, following B-ALL/BM-MSC interactions, contributes to chemotherapy resistance [48]. This evidence concerns the gene NFKB1 and precursor B-cell acute lymphoblastic leukemia.